Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression
Part of paid clinical trials in New York, New York.
- Sponsor
- City University of New York, School of Public Health
- Study ID
- NCT06119854
- Status
- Completed
Conditions
- Anxiety
- COVID-19
- Depression
- Misinformation
- Vaccine Hesitancy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Attitudinal inoculation — BEHAVIORALA brief video focused on bolstering resistance to mis/disinformation about the COVID vaccine. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
- Cognitive-behavioral therapy-informed intervention — BEHAVIORALA brief video using a CBT-informed approach and focused on addressing barriers to COVID-19 vaccination. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
- Conventional public health messaging — BEHAVIORALA brief video conveying conventional public health messaging adapted from a review of public health public service announcements with no inoculation messaging. Participants will receive two messages via text or email (1 and 3 days after the inoculation intervention). These messages will include reminders to get vaccinated.
Study Details
The COVID-19 pandemic has led to a mis/disinformation ecosystem that promotes divergent views of vaccine efficacy, as well as the legitimacy of science and medicine. Individuals are confronted with vaccine-related information from a multitude of sources, posing a challenge to identifying inaccurate information. COVID-19 vaccine uptake is lower among people with anxiety and depression than in the general population, due in part to higher levels of vaccine hesitancy. The prevalence of anxiety and depressive symptoms among US adults increased significantly during the COVID pandemic and has remained elevated. Interventions capable of mitigating the impact of vaccine hesitancy and mis/disinformation among undervaccinated people with anxiety or depression are therefore an urgent priority. Emerging evidence suggests that reasons for vaccine hesitancy and the impact of conventional vaccination messaging differ between those with and without mental health symptoms. There may also be added challenges overcoming logistical barriers to vaccination for people with anxiety or depressive symptoms. The investigators aim to determine the effectiveness of two different brief digital intervention strategies compared with conventional public health messaging for increasing vaccine uptake in undervaccinated adults with and without anxiety or depressive symptoms. Attitudinal inoculation is a brief, scalable strategy that leverages the power of narrative, values, and emotion to strengthen resistance to mis/disinformation and reduce hesitancy. Though this approach has been shown to decrease COVID-19 vaccine hesitancy among US adults, the extent to which this approach increases COVID-19 vaccination remains unknown. Cognitive-behavioral therapy (CBT) is an evidence-based intervention for anxiety and depression. However, the efficacy of incorporating CBT-informed messaging in a vaccine promotion intervention has not been tested. The investigators hypothesize that both attitudinal inoculation and CBT-style communication will be more effective than conventional public health messaging to increase COVID-19 vaccination. The investigators also hypothesize that the CBT-informed intervention will be more effective than the attitudinal inoculation intervention for increasing COVID-19 vaccination among participants with symptoms of anxiety or depression.
Key Dates
- Start date
- Apr 15, 2024
- Status verified
- Sep 2025
- Primary completion
- Jun 13, 2024
- Completion
- Nov 15, 2024
Study Design
- Enrollment
- 1,419 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Attitudinal inoculation interventionParticipants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation.
- Experimental: Cognitive behavioral therapy-informed interventionParticipants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging.
- Active Comparator: Conventional public health messagingParticipants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging.
Primary Outcome Measure
Self-reported Receipt of COVID Vaccine Dose by 4 Weeks Post-intervention [ Time Frame: 4 weeks post-intervention ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| CUNY Graduate School of Public Health & Health Policy | New York | New York | 10027 | - |
Find similar trials in New York, NY
Related Studies
- Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT StudyPHASE3 · Recruiting · Ansun Biopharma, Inc. · Duarte, California
- ARMOR Study: COVID-19 Seroprevalence Among Healthcare WorkersRecruiting · Columbia University · New York, New York
- Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After ConvalescenceRecruiting · Columbia University · New York, New York
- Lay-Delivered Behavioral Activation in Senior CentersRecruiting · University of Washington · Brandon, Florida